Evolutec Group plc ("Evolutec") is classed as an investment company under the AIM Rules. The investment policy of Evolutes' has been to seek a single investment, most probably of a UK or European business, in either the technology, healthcare or service related sectors.

The main country of operation is England.

The boards of Evolutec and Nanoco Tech Public Limited Company ("Nanoco") have reached agreement on the terms of recommended share acquisition by Evolutec of the entire issued and to be issued share capital of Nanoco to be effected by means of a court approved scheme of arrangement. Admission is sought as a result of a reverse take-over under Rule 14.

Nanoco is a leading nanotechnology company involved in the development and manufacture of fluorescent semi-conducting materials called quantum dots. Quantum dots are a platform technology with uses in a wide range of applications from life sciences through to optoeletronics dominated by solid state lighting, photovoltaics and next generation displays.

Quantum dot based applications have the ability to potentially offer significant benefits in performance and energy savings compared to those materials currently used.

Listing exchange: AIM

Expected first day of trading: 2009-04-30

Expected money raised: TBC